1Point Pharma ApS

Private limited companyCVR 44804425København VActive

1Point Pharma ApS is a private limited company, based in København V, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2024. The company made a loss in both 2024 and 2025, most recently DKK 1.5m. The company is new and has been registered for 2 years. Equity fell to DKK 932k in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 1.3m−264.1% vs. 2024
Net profit−DKK 1.5m−150.5% vs. 2024
EquityDKK 932k−42.3% vs. 2024
Employees5latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss grew: from DKK 593k to DKK 1.5m (2024 → 2025).
  • Equity fell 42% (2024 → 2025), to DKK 932k.

Employees

  • 1 more employees than a year earlier: 5 (07/2026) against 4 (07/2025).

Registrations, last 24 months

  • 27/10/2025: Share capital changed from 103,896 DKK to 104,296 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2024–2025 · amounts in DKK thousand

Equity and net profit

−DKK 1.5m−DKK 1m−DKK 500kDKK 0DKK 500kDKK 1mDKK 1.5m20242025
EquityNet profit
Financial figures for 1Point Pharma ApS
20242025Change
Revenuenot statednot stated–
Gross profit−361−1,314−264.1%
Operating profit (EBIT)−760−1,875−146.6%
Profit before tax−760−1,903−150.4%
Net profit−593−1,485−150.5%
Total assets1,8863,451+83%
Equity1,617932−42.3%
Liabilities2682,518+838.4%
Cash and cash equivalents1,0141,755+73.1%
Average number of employees14+300%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 2mDKK 0DKK 2mDKK 4mDKK 6mDKK 8mDKK 10mDKK 12m20242025
Gross profitMedian, the industry (232 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Loss for 2 years in a row

    Net result has been negative in 2024–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

  • Equity fell sharply

    Equity fell 42% from 2024 to 2025 (DKK 1.6m to DKK 932k).

    How is this calculated?

    Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

2 financial years
Annual reports for 1Point Pharma ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202520/06/2026The companyPDF not statedXBRL
202429/04/2024 – 31/12/202425/06/2025The companyPDF not statedXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
01234509/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

232 companies in the database

Comparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.

Gross profit−DKK 1.3mNo. 230 of 232
Better than 1% of the companies in the industry
EquityDKK 932kNo. 192 of 232
Better than 17% of the companies in the industry
Number of employees5No. 146 of 232
Better than 37% of the companies in the industry

Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.

DKK 100kDKK 1.4mDKK 19.1mDKK 263.2mDKK 1.5bn
Distribution of gross profit for 225 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 68,941of 69,742
Better than 1%
No. 34,588of 69,964
Better than 51%
Same industry and fewer than 20 employees150 companies in the comparison
No. 148of 150
Better than 1%
No. 111of 150
Better than 26%
Companies that are founded within the last five years16,662 companies in the comparison
No. 16,343of 16,614
Better than 2%
No. 4,084of 16,661
Better than 75%
All companies of type ApS66,508 companies in the comparison
No. 65,750of 66,379
Better than 1%
No. 30,440of 66,505
Better than 54%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of pharmaceutical goods and nursing supplies
Gross profit
  1. 1Point Pharma ApS−DKK 1.3m
  2. Ambu A/SDKK 3.6bn
  3. Stada Nordic ApSDKK 687m
Net profit
  1. 1Point Pharma ApS−DKK 1.5m
  2. Ambu A/SDKK 609m
  3. Stada Nordic ApSDKK 54.6m
Equity
  1. 1Point Pharma ApSDKK 932k
  2. Ambu A/SDKK 6bn
  3. Stada Nordic ApSDKK 346.3m
Employees
  1. 1Point Pharma ApS5
  2. Ambu A/S619
  3. Stada Nordic ApS51

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Holdingselskabet House of Lundorff APS25%
  • Lease-A-Brain ApS33.33%
  • GJ Invest ApS10%
  • DD Holding 89 ApS10%
1Point Pharma ApS

Management

5 active registrations

Executive management

Executive management at 1Point Pharma ApS
NameRoleAppointed
Morten Carl MadsenDirector29/04/2024

Board of directors

Board of directors at 1Point Pharma ApS
NameRoleAppointed
Flemming Sylvang VideriksenBoard member20/09/2024
Michael Lundorff-HansenBoard member20/09/2024
Pernille Hasfeldt LundBoard member20/09/2024
Morten Carl MadsenChair of the board20/09/2024
Founders
Lease-A-Brain ApS

Signing rule: Selskabet tegnes af direktøren eller af den samlede bestyrelse.

Address and production units

1 active production units

Christians Brygge 28
1559 København V

København Municipality · Postcode 1559

Other companies at the address (8)

Production units
Production unitAddressEmployeesP number
1Point Pharma ApSChristians Brygge 28, 1, 1559 København V51030322637

Purpose

Selskabets formål er at drive virksomhed med salg og distribution af lægemidler samt at drive konsulentvirksomhed og anden virksomhed, der står i forbindelse hermed.

The purpose is quoted from the register in Danish.

Changes year by year

29 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20252 changescapital 1 · accounts 1
  • Share capital changed from 103,896 DKK to 104,296 DKK
  • Annual report for 2024 published
202426 changescapital 3 · management 5 · ownership 16 · address 1 · founded 1
  • Share capital changed from 64,935 DKK to 103,896 DKK
  • Flemming Sylvang Videriksen appointed board member
  • Michael Lundorff-Hansen appointed board member
  • Pernille Hasfeldt Lund appointed board member
  • Morten Carl Madsen appointed chair of the board
  • GJ Invest ApS registered as owner (10%)
  • Lease-A-Brain ApS registered as owner (33.33%)
  • Holdingselskabet House of Lundorff APS registered as owner (25%)
  • DD Holding 89 ApS registered as owner (10%)
  • Jesper Schaltz Andersen is no longer registered as owner
  • David Skjald Damkjær is no longer registered as owner
  • Lease-A-Brain ApS is no longer registered as owner
  • Moved to Christians Brygge 28, 1, 1559 København V
  • Share capital changed from 54,545 DKK to 64,935 DKK
  • Lease-A-Brain ApS registered as owner (50%)
  • Jesper Schaltz Andersen registered as owner (15%)
  • David Skjald Damkjær registered as owner (20%)
  • Lease-A-Brain ApS is no longer registered as owner
  • David Skjald Damkjær is no longer registered as owner
  • Share capital changed from 40,000 DKK to 54,545 DKK
  • Lease-A-Brain ApS registered as owner (66.67%)
  • David Skjald Damkjær registered as owner (25%)
  • Lease-A-Brain ApS is no longer registered as owner
  • Registered as 1Point Pharma ApS
  • Morten Carl Madsen appointed director
  • Lease-A-Brain ApS registered as owner (100%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction